Advertisement

SkinHealth Systems Inc. SKIN

Set alert

Price alert · SKIN

All alert types
9.94 USD -0.21 -2.07%

At close · Oct 30

9.94 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
9.74 × 1
Ask
10.26 × 1
9.68 Day range 10.26
1.26 52-week range 31.20
YTD
+615.11%
1 year
+604.96%
Open
10.26
Prev close
10.15
Mkt cap
64.76M
Vol
75.32K
Avg vol
25.97K
EPS
-4.60
P/E
0.00
Div yield
0.00%
More statistics
Low
9.68
High
10.26
Forward P/E
-9.00
Beta
0.91
Short ratio
8.46
Inst. own
87.00%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.58
200-d avg
2.17
1y target
1.72

MAX chart

Chart tools
Interval

Events in this range
  • Mar 12, 2024Earnings: -0.07; estimate -0.11; surprise 36.36%
  • May 9, 2024Earnings: -0.1; estimate -0.14; surprise 28.57%
  • May 9, 2024Earnings: —; estimate -0.14; surprise —%
  • May 13, 2024Rating: DA Davidson · Buy → Buy
  • Jul 11, 2024Rating: Piper Sandler · Underweight → Underweight
  • Jul 26, 2024Rating: Stifel · Hold → Hold
  • Aug 8, 2024Earnings: -0.1; estimate -0.05; surprise -100%
  • Aug 8, 2024Earnings: —; estimate -0.05; surprise —%
  • Aug 9, 2024Rating: Piper Sandler · Underweight → Underweight
  • Aug 12, 2024Rating: Canaccord Genuity · Hold → Hold
  • Nov 12, 2024Earnings: -0.15; estimate -0.12; surprise -25%
  • Nov 13, 2024Rating: Canaccord Genuity · Hold → Hold
  • Oct 14, 2026Split: 1 for 20
Signals (95)
NameDateAgo
SMA: BearishJul 27, 20263 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BearishMay 4, 20266 months ago
MACD: Sell SignalMar 23, 20267 months ago
SMA: BearishFeb 16, 20268 months ago
SMA: BullishDec 29, 202510 months ago
MACD: Buy SignalDec 29, 202510 months ago
RSI: OverboughtDec 29, 202510 months ago
SMA: BearishSep 29, 20251 year ago
MACD: Sell SignalSep 29, 20251 year ago
SMA: BearishSep 22, 20251 year ago
SMA: BullishAug 4, 20251 year ago
SMA: BullishAug 4, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BearishJul 14, 20251 year ago
SMA: BullishMay 5, 20251 year ago
SMA: BullishMay 5, 20251 year ago
MACD: Buy SignalMay 5, 20251 year ago
RSI: OversoldApr 14, 20251 year ago
MACD: Sell SignalMar 17, 20251 year ago
SMA: BearishFeb 24, 20251 year ago
SMA: BearishFeb 17, 20251 year ago
SMA: BullishFeb 10, 20251 year ago
SMA: BullishFeb 10, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BullishJan 13, 20251 year ago
SMA: BearishJan 6, 20251 year ago
SMA: BullishDec 30, 20241 year ago
SMA: BullishDec 23, 20241 year ago
SMA: BearishDec 16, 20241 year ago
SMA: BullishDec 9, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BearishSep 2, 20242 years ago
SMA: BullishAug 19, 20242 years ago
MACD: Buy SignalAug 19, 20242 years ago
RSI: OversoldJul 29, 20242 years ago
RSI: OversoldJun 17, 20242 years ago
MACD: Sell SignalMay 27, 20242 years ago
SMA: BearishApr 15, 20242 years ago
SMA: BearishApr 15, 20242 years ago
SMA: BullishApr 8, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BullishMar 18, 20242 years ago
SMA: BullishFeb 12, 20242 years ago
SMA: BearishFeb 5, 20242 years ago
SMA: BullishJan 22, 20242 years ago
RSI: OversoldJan 1, 20242 years ago
MACD: Buy SignalDec 25, 20232 years ago
RSI: OversoldOct 16, 20233 years ago
RSI: OversoldAug 21, 20233 years ago
MACD: Sell SignalMay 8, 20233 years ago
SMA: BearishMay 1, 20233 years ago
SMA: BearishApr 24, 20233 years ago
SMA: BullishMar 20, 20233 years ago
SMA: BearishMar 6, 20233 years ago
SMA: BullishFeb 27, 20233 years ago
SMA: BearishFeb 13, 20233 years ago
SMA: BullishJan 9, 20233 years ago
MACD: Buy SignalJan 9, 20233 years ago
MACD: Sell SignalDec 12, 20223 years ago
MACD: Buy SignalNov 28, 20223 years ago
MACD: Sell SignalNov 14, 20223 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BearishOct 17, 20224 years ago
SMA: BullishOct 3, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BearishAug 8, 20224 years ago
SMA: BullishAug 1, 20224 years ago
SMA: BullishJul 25, 20224 years ago
SMA: BearishJul 18, 20224 years ago
SMA: BullishJun 20, 20224 years ago
MACD: Buy SignalJun 20, 20224 years ago
SMA: BearishMay 30, 20224 years ago
SMA: BullishMay 23, 20224 years ago
SMA: BearishApr 4, 20224 years ago
SMA: BullishFeb 21, 20224 years ago
SMA: BearishJan 3, 20224 years ago
SMA: BullishDec 20, 20214 years ago
SMA: BearishDec 13, 20214 years ago
SMA: BearishNov 29, 20214 years ago
SMA: BullishNov 15, 20214 years ago
SMA: BearishNov 8, 20214 years ago
MACD: Sell SignalNov 8, 20214 years ago
RSI: OverboughtOct 25, 20215 years ago
RSI: OverboughtAug 2, 20215 years ago
RSI: OverboughtMay 10, 20215 years ago
SMA: BullishApr 26, 20215 years ago
SMA: BearishMar 22, 20215 years ago
SMA: BullishMar 15, 20215 years ago
SMA: BearishFeb 22, 20215 years ago
SMA: BullishFeb 8, 20215 years ago

Key statistics

Market cap
178.74M
Enterprise value
390.66M
Trailing P/E
0.00
Forward P/E
-9.00
PEG ratio
0.00
Price / sales
0.51
Price / book
2.99
EPS (TTM)
-0.39
Beta
0.91
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-8.10%
Revenue (TTM)
347.62M
Revenue growth
-19.10%
Free cash flow
-375.50K
Total cash
358.89M
Total debt
568.33M
Return on equity
-37.64%
Shares outstanding
124.12M
Short % of float
16.11%
50-day average
1.58
200-day average
2.17

Analyst view

Consensus: hold

Hold
Price target (mean) 1.72 -82.7% downside
Target (low)
1.00
Target (mean)
1.72
Target (high)
2.00
Ratings (0m) 10 0 buy · 7 hold · 3 sell
  • Strong buy0
  • Buy0
  • Hold7
  • Sell0
  • Strong sell3

Next earnings

Aug 8, 2024

Expected Aug 8, 2024. Consensus EPS estimate -0.09.

Earnings history

Financials — quick view

All financials
SKIN Revenue — quarterly 72.11M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SKIN Net income — quarterly -2.67M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SKIN EPS — quarterly -0.40
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SKIN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 2024-0.12-0.15-0.03-25.00%
Aug 8, 2024Jun 1, 2024-0.05-0.10-0.05-100.00%
Aug 8, 2024Jun 1, 2024-0.05———
May 9, 2024Mar 1, 2024-0.14-0.10+0.04+28.57%
May 9, 2024Mar 1, 2024-0.14———
Mar 12, 2024Dec 1, 2023-0.11-0.07+0.04+36.36%

Upgrades / downgrades

SKIN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024Canaccord GenuitymainHoldHold
Aug 12, 2024Canaccord GenuitymainHoldHold
Aug 9, 2024Piper SandlerreitUnderweightUnderweight
Jul 26, 2024StifelmainHoldHold
Jul 11, 2024Piper SandlermainUnderweightUnderweight
May 13, 2024DA DavidsonmainBuyBuy

About SkinHealth Systems Inc.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Sector
Consumer Defensive
Industry
Household & Personal Products
Country
United States

News

Your note

Sign in to keep a note on SKIN — it syncs with the Stock Master app.

Insider holders

SKIN insider holders
InsiderRelationLatest transactionDateShares held
BECK MARLA MALCOLMChief Executive OfficerStock Award(Grant)Apr 8, 20241,078,210
CAPELLAS MICHAEL DDirectorStock Award(Grant)Jul 7, 2024276,146
FEW JULIUSDirectorStock Award(Grant)Jul 7, 2024194,341
GRUBER DESIREEDirectorSaleNov 19, 2024119,514
KERRICK MICHELLE C.DirectorStock Award(Grant)Jul 7, 2024116,762
MILLER BRIAN CHRISTOPHERDirectorStock Award(Grant)Jul 7, 2024169,984

Institution ownership

SKIN institution ownership
Holder% heldSharesValueReported
FMR, LLC14.99%18,603,03726.79MSep 29, 2024
Janus Henderson Group PLC9.03%11,209,40816.14MSep 29, 2024
Blackrock Inc.4.53%5,620,7528.09MSep 29, 2024
Vanguard Group Inc4.46%5,536,4337.97MSep 29, 2024
Braidwell LP 3.26%4,049,6945.83MSep 29, 2024
Jacobs Levy Equity Management, Inc.2.01%2,499,6523.60MSep 29, 2024

Fund ownership

SKIN fund ownership
Holder% heldSharesValueReported
Janus Henderson Contrarian Fund8.96%11,117,96516.01MSep 29, 2024
Fidelity Growth Company Fund3.10%3,848,9245.54MOct 30, 2024
Vanguard Total Stock Market Index Fund2.17%2,698,0713.89MSep 29, 2024
iShares Russell 2000 ETF1.59%1,979,4562.85MOct 30, 2024
Fidelity Growth Company K6 Fund1.15%1,430,4562.06MOct 30, 2024
Vanguard Extended Market Index Fund1.02%1,266,0611.82MSep 29, 2024
Advertisement